ABSTRACT
Toxoplasma gondii (T. gondii) is an obligate intracellular parasite that can infect almost all warm-blooded animals, including humans, and one-third of the global population is thought to be infected with this parasite. Infection can occur through consumption of contaminated food, contact with an infected host, or congenital transmission. While toxoplasmosis is asemptomatic in people with a healthy immune system, it can cause severe infections in people with a suppressed immune system or with immunodeficiency. In addition to causing diseases in humans, it also causes infections in livestock and may result in stillbirth and abortion in sheep and goats. There is no 100% effective medicine or vaccination against the parasite that causes major clinical symptoms and financial losses. There is a need for an effective, safe, and durable vaccine that can provide protective immunity for use in humans and animals. Vaccination studies against toxoplasmosis have gathered speed since the 1990s. Today, studies can be carried out to develop effective and safe vaccines depending on the developments in molecular biology, biotechnology, and immunology. DNA vaccines are a promising vaccine platform against toxoplasmosis because they are easy to produce, they are safe, they do not need a cold chain, and they can stimulate both humoral and cellular immune responses. This review provides an overview of the complex life cycle, pathogenesis, and epidemiology of the parasite; the immune response that develops in the host against the infection it causes; and the DNA vaccines developed against toxoplasmosis and these vaccines.
Keywords: DNA vaccines, toxoplasma, immunization
References
1
Loh FK, Nathan S, Chow SC, Fang CM. Vaccination challenges and strategies against long-lived Toxoplasma gondii. Vaccine 2019; 37: 3989-4000.
2
Sibley LD, Khan A, Ajioka JW, Rosenthal BM. Genetic diversity of Toxoplasma gondii in animals and humans. Philos Trans R Soc Lond B Biol Sci 2009; 364: 2749-61.
3
Gürüz AY, Delibaş SB. Toksoplazmozis ve İmmunolojisi. Tıbbi ve Veteriner İmmunoparazitoloji, Özcel MA, İnci A, Turgay N, Köroğlu E. Editors. Türkiye Parazitoloji Derneği Yayınları. İzmir; 2007.p.167-94.
4
Wang JL, Zhang NZ, Li TT, He JJ, Elsheikha HM, Zhu XQ. Advances in the development of anti-Toxoplasma gondii vaccines: challenges, opportunities, and perspectives. Trends Parasitol 2019; 35: 239-53.
5
Lori A, Avramopoulos D, Wang AW, Mulle J, Massa N, Duncan EJ, et al. Polygenic risk scores differentiate schizophrenia patients with Toxoplasma gondii compared to toxoplasma seronegative patients. Compr Psychiatry 2021; 152236.
6
Azizy B, Hamid N, Hamidynejat H. Study the Relationship Between Toxoplasma gondii Infection and Autism Disorder in Children. Journal of Veterinary Research 2021; 75: 413-7.
7
Hodge JM, Coghill AE, Kim Y, Bender N, Smith‐Warner SA, Gapstur S, et al. Toxoplasma gondii infection and the risk of adult glioma in two prospective studies. Int J Cancer 2021.
8
Buxton, D, Innes EA. A commercial vaccine for ovine toxoplasmosis. Parasitology 1995; 110(Suppl 1): S11-6.
9
Gurunathan S, Wu CY, Freidag BL, Seder RA. DNA vaccines: a key for inducing long-term cellular immunity. Curr Opin Immunol 2000; 12: 442-7.
10
Sefidi-Heris Y, Jahangiri A, Mokhtarzadeh A, Shahbazi MA, Khalili S, Baradaran B, et al. Recent progress in the design of DNA vaccines against tuberculosis. Drug Discov Today 2020; 25: 1359-6446(20)30345-7.
11
Coban C, Koyama S, Takeshita F, Akira S, Ishii KJ. Molecular and cellular mechanisms of DNA vaccines. Hum Vaccin 2008; 4: 453-6.
12
Duong HTT, Kim NW, Thambi T, Phan VG, Lee MS, Yin Y, et al. Microneedle arrays coated with charge reversal pH-sensitive copolymers improve antigen presenting cells-homing DNA vaccine delivery and immune responses. J Control Release 2018; 269: 225-34.
13
Chavda VP, Pandya R, Apostolopoulos V. DNA vaccines for SARS-CoV-2: toward third-generation vaccination era. Expert Rev Vaccines 2021; 20: 1549-60.
14
Weiss LM, Dubey JP. Toxoplasmosis: A history of clinical observations. Int J Parasitol 2009; 39: 895-901.
15
Dubey JP. Toxoplasma, Neospora, Sarcocystis, and other tissue cyst forming Coccidia of humans and animals. Parasitic Protozoa 1993; 6: 5-57.
16
Dubey JP, Beattie CP. Toxoplasmosis of animals and man. CRC Press Inc; 1988.p.220.
17
Altıntaş K. Tıbbi Parazitoloji. Ankara: Nobel Tıp Yayınları; 2002.
18
Döşkaya M, Caner A, Ajzenberg D, Değirmenci A, Dardé ML, Can H, et al. Isolation of Toxoplasma gondii strains similar to Africa 1 genotype in Turkey. Parasitol Int 2013; 62: 471-4.
19
Pagheh AS, Sarvi S, Sharif M, Rezaei F, Ahmadpour E, Dodangeh S, et al. Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review. Comp Immunol Microbiol Infect Dis 2020; 69: 101414.
20
Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30: 1217-58.
21
Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 1998; 11: 267-99.
22
Montoya JG, Remington JS. Toxoplasma gondii. Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone Inc; 2000.p.2858-88.
23
Ferguson DJP. Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host. Int J Parasitol 2004; 34: 347-60.
24
Kasper LH, Boothroyd JC. Toxoplasma gondii and toxoplasmosis. Immunology and Molecular Biology of Parasitic Infections 1993; 269-301.
25
Beghetto E, Nielsen HV, Porto PD, Buffolano W, Guglietta S, Felici F, et al. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. J Infect Dis 2005; 191: 637-45.
26
Montoya J, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-76.
27
Jones JL, Lopez A, Wilson M. Congenital toxoplasmosis. Am Fam Physician 2003; 67: 2131-8.
28
Minkoff H, Remington JS, Holman S, Ramirez R, Goodwin S, Landesman S. Vertical transmission of toxoplasma by human immunodeficiency virus-infected women. Am J Obstet Gynecol 1997; 176: 555-9.
29
Dupont CD, Christian DA, Hunter CA. Immune response and immunopathology during toxoplasmosis. Semin Immunopathol 2012; 34: 793-813.
30
Guo M, Dubey JP, Hill D, Buchanan RL, Gamble H, Jones JL, et al. Prevalence and risk factors for Toxoplasma gondii infection in meat animals and meat products destined for human consumption. J Food Prot 2015; 78: 457-76.
31
Dubey JP. The history of Toxoplasma gondii--the first 100 years. J Eukaryot Microbiol 2008; 55: 467-75.
32
Beaman M, Wong SY, Remington JS. Toxoplasma gondii. In: Mandell, Douglas and Bennett’s Principles. Practice of Infectious Diseases Churchill Livingston; 1994p.2455-75.
33
Halici-Ozturk F, Yakut K, Öcal FD, Erol A, Gökay S, Çağlar AT, et al. Seroprevalence of Toxoplasma gondii infections in Syrian pregnant refugee women in Turkey. Eur J Obstet Gynecol Reprode Bio 2021; 256: 91-4.
34
Wiengcharoen J, Thompson RA, Nakthong C, Rattanakorn P, Sukthana Y. Transplacental transmission in cattle: is Toxoplasma gondii less potent than Neospora caninum?. Parasitol Res 2011; 108: 1235-41.
35
Dubey JP, Gamble HR, Hill D, Sreekumar C, Romand S, Thulliez P. High prevalence of viable Toxoplasma gondii infection in market weight pigs from a farm in Massachusetts. J Parasitol 2002; 88: 1234-8.
36
Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001; 154: 357-65.
37
Owusu-Dommey A, Pogreba-Brown K, Villa-Zapata L. Seroprevalence of Toxoplasma gondii in the US: Evidence from a representative cross-sectional survey. Parasitol Int 2020; 79: 102175.
38
El Bissati K, Levigne P, Lykins J, Adlaoui EB, Barkat A, Berraho A, et al. Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis. Emerg Microbes Infect 2018; 7: 165.
39
Holland GN. Ocular toxoplasmosis: a global reassessment: Part I: epidemiology and course of disease. Am J Ophthalmol 2003; 136: 973-88.
40
Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild A, et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998; 36: 2900-6.
41
Ekmen H. Koyun ve Sığırlarda Toksoplazma Antikorları. Mikrobiyoloji Bülteni 1967; 1: 243-8.
42
Aslantaş O, Ozdemir V, Kiliç S, Babür C. Seroepidemiology of leptospirosis, toxoplasmosis, and leishmaniosis among dogs in Ankara, Turkey. Vet Parasitol 2005; 129: 187-91.
43
Babür C, Inci A, Karaer Z. Detection on seropositivity of Toxoplasma gondii in sheep and goats in around of Çankiri using Sabin-Feldman dye test. Turkiye Parazitol Derg 1997; 21: 409-12.
44
Tekay F, Özbek E. Çiğ köftenin yaygın tüketildiği Şanlıurfa ilinde kadınlarda Toxoplasma gondii seroprevalansı. Turkiye Parazitol Derg 2007; 31: 176-9.
45
Mor N, Arslan MO. Seroprevalence of Toxoplasma gondii in sheep in Kars Province. Kafkas Univ Vet Fak Derg 2007; 13: 165-70.
46
Karabulut A, Polat Y, Türk M, Balci YI. Evaluation of rubella, Toxoplasma gondii, and cytomegalovirus seroprevalences among pregnant women in Denizli province. Turkish Journal of Medical Sciences 2011; 41: 159-64.
47
Ertug S, Okyay P, Turkmen M, Yuksel H. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health 2005; 5: 66.
48
Cevizci S, Bakar C. Halk Sağlığı bakışıyla Toxoplasma gondii. Türkiye Halk Sağlığı Dergisi 2013; 11: 45-58.
49
Benenson MW, Takafuji ET, Lemon SM, Greenup RL, Sulzer AJ. Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. N Engl J Med 1982; 307: 666-9.
50
Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 2005; 6: 41-61.
51
Doganci L, Tanyuksel M, Araz ER, Besirbellioglu BA, Erdem U, Ozoguz CA, et al. A probable outbreak of toxoplasmosis among boarding school students in Turkey. Clin Microbiol Infect 2006; 12: 672-4.
52
Balasundaram MB, Andavar R, Palaniswamy M, Venkatapathy N. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol 2010; 128: 28-32.
53
Palanisamy M, Madhavan B, Balasundaram MB, Andavar R, Venkatapathy N. Outbreak of ocular toxoplasmosis in Coimbatore, India. Indian J Ophthalmol 2006; 54: 129-31.
54
da Costa MA, Pinto‐Ferreira F, de Almeida RPA, Martins FDC, Pires AL, Mareze M, et al. Artisan fresh cheese from raw cow’s milk as a possible route of transmission in a toxoplasmosis outbreak, in Brazil. Zoonoses Public Health 2020; 67: 122-9.
55
Ajioka JW, Fitzpatrick JM, Reitter CP. Toxoplasma gondii genomics: shedding light on pathogenesis and chemotherapy. Expert Rev Mol Med 2001; 3: 1-19.
56
Alexander DL, Mital J, Ward GE, Bradley P, Boothroyd JC. Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles. PLoS Pathog 2005; 1: e17.
57
Zhang Y, Lai BS, Juhas M, Zhang Y. Toxoplasma gondii secretory proteins and their role in invasion and pathogenesis. Microbiol Res 2019; 227: 126293.
58
Rezaei F, Sarvi S, Sharif M, Hejazi SH, Pagheh SA, Aghayan SA, Daryani A. A systematic review of Toxoplasma gondii antigens to find the best vaccine candidates for immunization. Microbial Pathog 2019; 126: 172-84.
59
Weiss LM, Kim, editors. In: Toxoplasma gondii: the model apicomplexan. Perspectives and methods. Elsevier; 2011.p.611.
60
Wang HL, Zhang TE, Yin LT, Pang M, Guan L, Liu HL, et al. Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in mice. PLoS One 2014; 9: e108377.
61
Zhao XY, Ewald, SE. The molecular biology and immune control of chronic Toxoplasma gondii infection. J Clin Invest 2020; 130: 3370-80.
62
Denkers EY. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. FEMS Immunol Med Microbiol 2003; 39: 193-203.
63
Henriquez FL, Woods S, Cong H, McLeod R, Roberts CW. Immunogenetics of Toxoplasma gondii informs vaccine design. Trends Parasitol 2010; 26: 550-5.
64
Filisetti D, Candolfi E. Immune response to Toxoplasma gondii. Ann Ist Super Sanita 2004; 40: 71-80.
65
Innes EA, Hamilton C, Garcia JL, Chryssafidis A, Smith D. A one health approach to vaccines against Toxoplasma gondii. Food Waterborne Parasitol 2019; 15: e00053.
66
Pier GB, Lyczak JB, Wetzler LM. Immunology, infection, and immunity. American Society for Microbiology, Washington D.C; 2004.p.697.
67
Bonenfant C, Dimier-Poisson I, Velge-Roussel F, Buzoni-Gatel, D, Del Giudice G, Rappuoli R et al. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii. Infect Immun 2001; 69: 1605-12.
68
İz SG, Döşkaya M, Caner A, Döşkaya AD, Rodriguez F, Gürüz Y, et al. A novel dual promoter DNA vaccine induces CD8+ response against Toxoplasma gondii sporozoite specific surface protein “sporoSAG” through non-apoptotic cells. Trials in Vaccinology 2014; 3: 81-8.
69
Henderson LM. Overview of marker vaccine and differential diagnostic test technology. Biologicals 2005; 33: 203-9.
70
Liu MA. DNA vaccines: a review. J Intern Med 2003; 253: 402-10.
71
Kutzler MA, Weiner DB. DNA vaccines: ready for prime time?. Nat Rev Genet 2008; 9: 776-88.
72
Qin F, Xia F, Chen H, Cui B, Feng Y, Zhang P, et al. A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications. Front Cell Dev Biol 2021; 9: 633776.
73
Siegrist CA. Vaccine immunology. Vaccines 2008; 5: 17-36.
74
Quan JH, Chu JQ, Ismail HAHA, Zhou W, Jo EK, Cha GH, et al. Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii. Clin Vaccine Immunol 2012; 19: 666-74.
75
Liu MA. DNA vaccines: an historical perspective and view to the future. Immunol Rev 2010; 239: 62-84.
76
Hasson SSAA, Al-Busaidi JKZ, Sallam TA. The past, current and future trends in DNA vaccine immunisations. Asian Pacific Journal of Tropical Biomedicine 2015; 5: 344-53.
77
Doria-Rose NA, Haigwood NL. DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods 2003; 31: 207-16.
78
Chen MC, Lin ZW, Ling MH. Near-infrared light-activatable microneedle system for treating superficial tumors by combination of chemotherapy and photothermal therapy. ACS Nano 2016; 10: 93-101.
79
Gary EN, Weiner DB. DNA vaccines: prime time is now. Curr Opin Immunol 2020; 65: 21-7.
80
Luxembourg A, Evans CF, Hannaman, D. Electroporation-based DNA immunisation: translation to the clinic. Expert Opin Biol Ther 2007; 7: 1647-64.
81
Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines 2012; 11: 189-209.
82
Xie X, Pascual C, Lieu C, Oh S, Wang J, Zou B, et al. Analgesic microneedle patch for neuropathic pain therapy. Acs Nano 2017; 11: 395-406.
83
Kassegne K, Abe EM, Chen, JH, Zhou XN. Immunomic approaches for antigen discovery of human parasites. Expert Rev Proteomics 2016; 13: 1091-101.
84
Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010; 33: 530-41.
85
Nielsen HV, Lauemøller SL, Christiansen L, Buus S, Fomsgaard A, Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding theSAG1 gene. Infect Immun 1999; 67: 6358-63.
86
Angus CW, Klivington-Evans D, Dubey JP, Kovacs JA. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 2000; 181: 317-24.
87
Vercammen M, Scorza T, Huygen K, De Braekeleer J, Diet R, Jacobs D, et al. DNA vaccination with genes Encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 2000; 68: 38-45.
88
Leyva R, Hérion P, Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitol Res 2001; 87: 70-9.
89
Fachado A, Rodriguez A, Angel SO, Pinto DC, Vila I, Acosta A, et al. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 2003; 21: 1327-35.
90
Scorza T, D’souza S, Laloup M, Dewit J, De Braekeleer J, Verschueren H, et al. A GRA1 DNA vaccine primes cytolytic CD8+ T cells to control acute Toxoplasma gondii infection. Infect Immun 2003; 71: 309-16.
91
Couper KN, Nielsen HV, Petersen E, Roberts F, Roberts CW, Alexander J. DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine 2003; 21: 2813-20.
92
Mohamed RM, Aosai F, Chen M, Mun HS, Norose K, Belal US, et al. Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes. Vaccine 2003; 21 2852-61.
93
Ismael AB, Sekkai D, Collin C, Bout D, Mévélec MN. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun 2003; 71: 6222-8.
94
Yang CD, Chang GN, Chao D. Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2. Parasitol Res 2004; 92: 58-64.
95
Nielsen HV, Di Cristina M, Beghetto E, Spadoni A, Petersen E, Gargano N. Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts. Exp Parasitol 2006; 112: 274-9.
96
Döşkaya M, Kalantari-Dehaghi M, Walsh CM, Hiszczyńska-Sawicka E, Davies DH, Felgner PL, et al. GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine. Vaccine 2007; 25: 1824-37.
97
Jongert E, De Craeye S, Dewit J, Huygen K. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol 2007; 29: 445-53.
98
Wang H, Liu Q, Liu K, Zhong W, Gao S, Jiang L, et al. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol Int 2007; 56: 263-8.
99
Dautu G, Munyaka B, Carmen G, Zhang G, Omata Y, Xuenan X, et al. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential. Exp Parasitol 2007; 116: 273-82.
100
Zhang J, He S, Jiang H, Yang T, Cong H, Zhou H, et al. Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice. Parasitol Res 2007; 101: 331-8.
101
Jongert E, Melkebeek V, De Craeye S, Dewit J, Verhelst D, Cox, E. An enhanced GRA1–GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine 2008; 26: 1025-31.
102
Peng GH, Yuan ZG, Zhou DH, He XH, Liu MM, Yan C, et al. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine 2009; 27: 6570-4.
103
Fang R, Nie H, Wang Z, Tu P, Zhou D, Wang L, et al. Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii. Vet Parasitol 2009; 164: 134-40.
104
Liu S, Shi L, Cheng YB, Fan GX, Ren HX, Yuan YK. Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice. Parasitol Res 2009; 105: 267-74.
105
Fang R, Feng H, Nie H, Wang L, Tu P, Song Q, et al. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model. Vaccine 2010; 28: 1803-7.
106
Hiszczyńska-Sawicka E, Li H, Xu JB, Olędzka G, Kur J, Bickerstaffe R, Stankiewicz M. Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations. Exp Parasitol 2010; 124: 365-72.
107
Liu MM, Yuan ZG, Peng GH, Zhou DH, He XH, Yan C, et al. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol Res 2010; 106: 1079-84.
108
Liu Q, Shang L, Jin H, Wei F, Zhu XQ, Gao H. The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18. Res Vet Sci 2010; 89: 93-7.
109
Machado AV, Caetano BC, Barbosa RP, Salgado APC, Rabelo RH, Garcia CC, et al. Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity. Vaccine 2010; 28: 3247-56.
110
Kikumura A, Fang H, Mun HS, Uemura N, Makino M, Sayama Y, et al. Protective immunity against lethal anaphylactic reaction in Toxoplasma gondii-infected mice by DNA vaccination with T. gondii-derived heat shock protein 70 gene. Parasitol Int 2010; 59: 105-11.
111
Yuan ZG, Zhang XX, He XH, Petersen E, Zhou DH, He Y, et al. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice. Clin Vaccine Immunol 2011; 18: 119-24.
112
Yuan ZG, Zhang XX, Lin RQ, Petersen E, He S, Yu M, et al. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 2011; 29: 6614-9.
113
Rashid I, Hedhli D, Moiré N, Pierre J, Debierre-Grockiego F, Dimier-Poisson I, Mévélec MN. Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis. Vaccine 2011; 29: 8838-46.
114
Khosroshahi KH, Ghaffarifar F, D’Souza S, Sharifi Z, Dalimi A. Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis. Vaccine 2011; 29: 778-83.
115
Makino M, Uemura N, Moroda M, Kikumura A, Piao LX, Mohamed RM, Aosai F. Innate immunity in DNA vaccine with Toxoplasma gondii-heat shock protein 70 gene that induces DC activation and Th1 polarization. Vaccine 2011; 29: 1899-905.
116
Yan HK, Yuan ZG, Petersen E, Zhang XX, Zhou DH, Liu Q, et al. Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1. Exp Parasitol 2011; 128: 38-43.
117
Sun XM, Zou J, AA ES, Yan WC, Liu XY, Suo X, et al. DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice. Parasit Vectors 2011; 4: 213.
118
Cui X, Lei T, Yang D, Hao P, Li B, Liu Q. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis. Vaccine 2012; 30: 2282-7.
119
Fang R, Feng H, Hu M, Khan MK, Wang L, Zhou Y, et al. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii. Vet Parasitol 2012; 187: 140-6.
120
Wu XN, Lin J, Lin X, Chen J, Chen ZL, Lin JY. Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice. Parasitol Res 2012; 111: 2001-9.
121
Wang PY, Yuan ZG, Petersen E, Li J, Zhang XX, Li XZ, et al. Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice. Clin Vaccine Immunol 2012; 19: 1916-20.
122
Meng M, He S, Zhao G, Bai Y, Zhou H, Cong H, et al. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice. Parasit Vectors 2012; 5: 273.
123
Zhou H, Min J, Zhao Q, Gu Q, Cong H, Li Y, et al. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant. Vaccine 2012; 30: 1800-6.
124
Yu L, Yamagishi J, Zhang S, Jin C, Aboge GO, Zhang H, et al. Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice. Parasitol Int 2012; 61: 481-6.
125
Li J, Han Q, Gong P, Yang T, Ren B, Li S, Zhang X. Toxoplasma gondii rhomboid protein 1 (TgROM1) is a potential vaccine candidate against toxoplasmosis. Vet Parasitol 2012; 184: 154-60.
126
Yan HK, Yuan ZG, Song HQ, Petersen E, Zhou Y, Ren D, et al. Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii. Clin Vaccine Immunol 2012; 19: 684-9.
127
Parthasarathy S, Fong MY, Ramaswamy K, Lau YL. Protective immune response in BALB/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii. Amk J Trop Med Hyg 2013; 88: 883-7.
128
Cong H, Zhang M, Xin Q, Wang Z, Li Y, Zhao Q, et al. Compound DNA vaccine encoding SAG1/SAG3 with A 2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii. Parasit Vectors 2013; 6: 63.
129
Meng M, Zhou A, Lu G, Wang L, Zhao G, Han Y, et al. DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c mice. BMC Infect Dis 2013; 13: 494.
130
Yuan ZG, Ren D, Zhou DH, Zhang XX, Petersen E, Li XZ, et al. Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model. Vaccine 2013; 31: 3135-9.
131
Tao Q, Fang R, Zhang W, Wang Y, Cheng J, Li Y, et al. Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice. Parasitol Res 2013; 112: 2871-7.
132
Zhang NZ, Huang SY, Zhou DH, Chen J, Xu Y, Tian WP, et al. Protective immunity against Toxoplasma gondii induced by DNA immunization with the gene encoding a novel vaccine candidate: calcium-dependent protein kinase 3. BMC Infect Dis 2013; 13: 512.
133
Zhang M, Zhao L, Song J, Li Y, Zhao Q, He S, Cong H. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection. Vaccine 2013; 31: 4536-40.
134
Chen J, Huang SY, Li ZY, Yuan ZG, Zhou DH, Petersen E, et al. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Vaccine 2013; 31: 1734-9.
135
Chen J, Huang SY, Zhou DH, Li ZY, Petersen E, Song HQ, Zhu XQ. DNA immunization with eukaryotic initiation factor-2a of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Vaccine 2013; 31: 6225-31.
136
Gong P, Huang X, Yu Q, Li Y, Huang J, Li J, et al. The protective effect of a DNA vaccine encoding the Toxoplasma gondii cyclophilin gene in BALB/c mice. Parasite Immunol 2013; 35: 140-6.
137
Zhao G, Zhou A, Lu G, Meng M, Sun M, Bai Y, et al. Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis. Parasit Vectors 2013; 6: 175.
138
Zhao G, Zhou A, Lv G, Meng M, Sun M, Bai Y, et al. Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis. BMC Infect Dis 2013; 13: 207.
139
Zhao HG, Huang FY, Guo JL, Tan GH. Evaluation on the immune response induced by DNA vaccine encoding MIC8 co-immunized with IL-12 genetic adjuvant against Toxoplasma gondii infection. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2013; 31: 284-9.
140
Liu Q, Wang F, Wang G, Zhao Q, Min J, Wang S, et al. Toxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2. Hum Vaccin Immunother 2014; 10: 184-91.
141
Chen J, Zhou DH, Li ZY, Petersen E, Huang SY, Song HQ, et al. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis. Exp Parasitol 2014; 139: 42-8.
142
Li ZY, Chen J, Petersen E, Zhou DH, Huang SY, Song HQ, et al. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice. Vaccine 2014; 32: 3058-65.
143
Zhang NZ, Huang SY, Xu Y, Chen J, Wang JL, Tian WP, Zhu XQ. Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5. Clin Vaccine Immunol 2014; 21: 924-9.
144
Lu G, Zhou A, Meng M, Wang L, Han Y, Guo J, et al. Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii. BMC Infect Dis 2014; 14: 3862.
145
Hassan IA, Wang S, Xu L, Yan R, Song X, Li X. DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice. Parasit Vectors 2014; 7: 431.
146
Cong H, Yuan Q, Zhao Q, Zhao L, Yin H, Zhou H, et al. Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice. Parasit Vectors 2014; 7: 145.
147
Xu Y, Zhang NZ, Tan QD, Chen J, Lu J, Xu QM, et al. Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model. BMC Infect Dis 2014; 14: 525.
148
Wang S, Hassan IA, Liu X, Xu L, Yan R, Song X, Li X. Immunological changes induced by Toxoplasma gondii Glutathione-S-Transferase (TgGST) delivered as a DNA vaccine. Res Vet Sci 2015; 99: 157-64.
149
Wang S, Wang Y, Sun X, Zhang Z, Liu T, Gadahi JA, et al. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha. BMC Infect Dis 2015; 15: 448.
150
Wang S, Wang Y, Sun X, Zhang Z, Liu T, Gadahi JA, et al. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii 10 kDa excretory–secretory antigen (TgESA10). Vet Parasitol 2015; 214: 40-8.
151
Cao A, Liu Y, Wang J, Li X, Wang S, Zhao Q, et al. Toxoplasma gondii: vaccination with a DNA vaccine encoding T-and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice. Vaccine 2015; 33: 6757-62.
152
Lu G, Wang L, Zhou A, Han Y, Guo J, Song P, et al. Epitope analysis, expression and protection of SAG5A vaccine against Toxoplasma gondii. Acta Trop 2015; 146: 66-72.
153
Chen J, Li ZY, Petersen E, Huang SY, Zhou DH, Zhu XQ. DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice. Expert Rev Vaccines 2015; 14: 617-24.
154
Grzybowski MM, Dziadek B, Gatkowska JM, Dzitko K, Długońska H. Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins. Parasitol Res 2015; 114: 4553-63.
155
Zhang NZ, Xu Y, Wang M, Petersen E, Chen J, Huang SY, Zhu XQ. Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice. Expert Rev Vaccines 2015; 14: 1289-97.
156
Zhou J, Wang L, Lu G, Zhou A, Zhu M, Li Q, et al. Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii. Parasite 2016; 23: 17.
157
Chen J, Li ZY, Petersen E, Liu WG, Zhu XQ. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii. Exp Parasitol 2016; 162: 18-23.
158
Gong P, Cao L, Guo Y, Dong H, Yuan S, Yao X, et al. Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice. Exp Parasitol 2016; 166: 131-6.
159
Wang L, Lu G, Zhou A, Han Y, Guo J, Zhou H, et al. Evaluation of immune responses induced by rhoptry protein 5 and rhoptry protein 7 DNA vaccines against Toxoplasma gondii. Parasite Immunol 2016; 38: 209-17.
160
Wang HL, Wang YJ, Pei YJ, Bai JZ, Yin LT, Guo R, et al. DNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in mice. Parasite 2016; 23: 4.
161
Sonaimuthu P, Ching XT, Fong MY, Kalyanasundaram R, Lau YL. Induction of protective immunity against toxoplasmosis in BALB/c mice vaccinated with Toxoplasma gondii Rhoptry-1. Front Microbiol 2016; 7: 808.
162
Tang X, Yin G, Qin M, Tao G, Suo J, Liu X, Suo X. Transgenic Eimeria tenella as a vaccine vehicle: expressing TgSAG1 elicits protective immunity against Toxoplasma gondii infections in chickens and mice. Sci Rep 2016; 6: 29379.
163
Rashid I, Moiré N, Héraut B, Dimier-Poisson I, Mévélec MN. Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route. Med Microbiol Immunol 2016; 206: 53-62.
164
Zhao Y, Li ZY, Chen J, Sun XL, Liu SS, Zhu XQ, Zhou DH. Protective efficacy of pVAX-RON5p against acute and chronic infections of Toxoplasma gondii in BALB/c mice. Exp Parasitol 2016; 163: 24-30.
165
Ahmadpour E, Sarvi S, Hashemi Soteh MB, Sharif M, Rahimi MT, Valadan R, et al. Evaluation of the immune response in BALB/c mice induced by a novel DNA vaccine expressing GRA 14 against Toxoplasma gondii. Parasite Immunol 2017; 39.
166
Ahmadpour E, Sarvi S, Soteh MBH, Sharif M, Rahimi MT, Valadan R, et al. Enhancing immune responses to a DNA vaccine encoding Toxoplasma gondii GRA14 by calcium phosphate nanoparticles as an adjuvant. Immunol Lett 2017; 185: 40-7.
167
Han Y, Zhou A, Lu G, Zhao G, Wang L, Guo J, et al. Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice. BMC Infect Dis 2017; 17: 59.
168
Yang WB, Zhou DH, Zou Y, Chen K, Liu Q, Wang JL, et al. Vaccination with a DNA vaccine encoding Toxoplasma gondii ROP54 induces protective immunity against toxoplasmosis in mice. Acta Trop 2017; 176: 427-32.
169
Zhou J, Wang L. SAG4 DNA and peptide vaccination provides partial protection against T. gondii infection in BALB/c mice. Front Microbiol 2017; 8: 1733.
170
Rahimi MT, Sarvi S, Sharif M, Abediankenari S, Ahmadpour E, Valadan R, et al. Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice. Parasitol Res 2017; 116: 609-16.
171
Song P, He S, Zhou A, Lv G, Guo J, Zhou J et al. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii. BMC Infect Dis 2017; 17: 19.
172
Liu Y, Cao A, Li Y, Li X, Cong H, He S, Zhou H. Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice. BMC Infect Dis 2017; 17: 403.
173
Zheng B, Ding J, Chen X, Yu H, Lou D, Tong Q, et al. Immuno-efficacy of a T. gondii secreted protein with an altered thrombospondin repeat (TgSPATR) as a novel DNA vaccine candidate against acute toxoplasmosis in BALB/c mice. Front Microbiol 2017; 8: 216.
174
Lu G, Zhou J, Zhou A, Han Y, Guo J, Song P, et al. SAG5B and SAG5C combined vaccine protects mice against Toxoplasma gondii infection. Parasitol Int 2017; 66: 596-602.
175
Zheng L, Hu Y, Hua Q, Luo F, Xie G, Li X, et al. Protective immune response in mice induced by a suicidal DNA vaccine encoding NTPase-II gene of Toxoplasma gondii. Acta Trop 2017; 166: 336-42.
176
Han Y, Zhou A, Lu G, Zhao G, Sha W, Wang L, et al. DNA vaccines encoding Toxoplasma gondii cathepsin C 1 induce protection against Toxoplasmosis in mice. Korean J Parasitol 2017; 55: 505-12.
177
Hu LY, Zhang NZ, Zhang FK, Wang M, Gao Q, Wang JL, et al. Resistance to Chronic Toxoplasma gondii infection induced by a DNA vaccine expressing GRA16. Biomed Res Int 2017; 2017: 1295038.
178
Chen K, Wang JL, Huang SY, Yang WB, Zhu WN, Zhu XQ. Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2). Parasite 2017; 24: 41.
179
Zulpo DL, Igarashi M, Sammi AS, Santos JRD, Sasse JP, Cunha IALD, et al. rROP2 from Toxoplasma gondii as a potential vaccine against oocyst shedding in domestic cats. Rev Bras Parasitol Vet 2017; 26: 67-73.
180
Zhu WN, Wang JL, Chen K, Yue DM, Zhang XX, Huang SY, et al. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice. Exp Parasitol 2017; 179: 20-7.
181
Zhang NZ, Gao Q, Wang M, Hou JL, Zhang FK, Hu LY, Zhu XQ. Protective efficacy against acute and chronic Toxoplasma gondii infection induced by immunization with the DNA vaccine TgDOC2C. Front Microbiol 2018; 9: 2965.
182
Li ZY, Lu J, Zhang NZ, Chen J, Zhu XQ. Immune responses induced by HSP60 DNA vaccine against Toxoplasma gondii infection in Kunming mice. Korean J Parasitol 2018; 56: 237-45.
183
Babaie J, Amiri S, Homayoun R, Azimi E, Mohabati R, Berizi M, et al. Immunization of C57BL/6 mice with GRA2 combined with MPL conferred partial immune protection against Toxoplasma gondii. Iran Biomed J 2018; 22: 22-32.
184
Vazini H, Ghafarifar F, Sharifi Z, Dalimi A. Evaluation of immune responses induced by GRA7 and ROP2 genes by DNA vaccine cocktails against acute toxoplasmosis in BALB/c mice. Avicenna J Med Biotechnol 2018; 10: 2-8.
185
Chu JQ, Huang S, Ye W, Fan XY, Huang R, Ye SC, et al. Evaluation of protective immune response induced by a DNA vaccine encoding GRA8 against acute toxoplasmosis in a murine model. Korean J Parasitol 2018; 56: 325-34.
186
Chen Y, Yu M, Hemandez JA, Li J, Yuan ZG, Yan H. Immuno-efficacy of DNA vaccines encoding PLP1 and ROP18 against experimental Toxoplasma gondii infection in mice. Exp Parasitol 2018; 188: 73-8.
187
Zhang Z, Li Y, Wang M, Xie Q, Li P, Zuo S, et al. Immune protection of rhoptry protein 21 (ROP21) of Toxoplasma gondii as a DNA vaccine against toxoplasmosis. Front Microbiol 2018; 9: 909.
188
Lu G, Zhou J, Zhao YH, Wang L. DNA vaccine ROP 29 from Toxoplasma gondii containing R848 enhances protective immunity in mice. Parasite Immunol 2018; 40: e12578.
189
Zhang Z, Li Y, Liang Y, Wang S, Xie Q, Nan X, et al. Molecular characterization and protective immunity of rhoptry protein 35 (ROP35) of Toxoplasma gondii as a DNA Vaccine. Vet Parasitol 2018; 260: 12-21.
190
Roozbehani M, Falak R, Mohammadi M, Hemphill A, Razmjou E, reza Meamar A, et al. Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection. Vaccine 2018; 36: 6124-32.
191
Gao Q, Zhang NZ, Zhang FK, Wang M, Hu LY, Zhu XQ. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin. BMC Infect Dis 2018; 18: 117.
192
Zhang NZ, Gao Q, Wang M, Elsheikha HM, Wang B, Wang JL, et al. Immunization with a DNA vaccine cocktail encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 genes protects mice against chronic toxoplasmosis. Front Immunol 2018; 9: 1505.
193
Zheng B, Lou D, Ding J, Zhuo X, Ding H, Kong Q, et al. GRA24-based DNA vaccine prolongs survival in mice challenged with a virulent Toxoplasma gondii strain. Front Immunol 2019; 10: 418.
194
Xu XP, Liu WG, Xu QM, Zhu XQ, Chen J. Evaluation of immune protection against Toxoplasma gondii infection in mice induced by a multi-antigenic DNA vaccine containing TgGRA24, TgGRA25 and TgMIC6. Parasite 2019; 26: 58.
195
Pagheh AS, Sarvi S, Gholami S, Asgarian-Omran H, Valadan R, Hassannia H, et al. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice. Microb Pathog 2019; 134: 103601.
196
Zhou J, Li C, Luo Y, Wang L. Antigenic Epitope Analysis and Efficacy Evaluation of GRA41 DNA Vaccine Against T. gondii Infection. Acta Parasitol 2019; 64: 471-8.
197
Alizadeh P, Ahmadpour E, Daryani A, Kazemi T, Spotin A, Mahami‐Oskouei M, et al. IL‐17 and IL‐22 elicited by a DNA vaccine encoding ROP13 associated with protection against Toxoplasma gondii in BALB/c mice. J Cell Physiol 2019; 234: 10782-8.
198
Zhang D, Jiang N, Chen Q. Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice. Vaccine 2019; 37: 1118-25.
199
Zheng B, Ding J, Lou D, Tong Q, Zhuo X, Ding H, et al. The virulence-related MYR1 protein of Toxoplasma gondii as a novel DNA vaccine against toxoplasmosis in mice. Front Microbiol 2019; 10: 734.
200
Mavi SA, Modarressi MH, Mohebali M, Shojaee S, Zeraati H, Teimouri A, et al. Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice. Infect Drug Resist 2019; 12: 2519-30.
201
Sobati H, Dalimi A, Kazemi, B, Ghaffarifar, F. Evaluation of Anti-Toxoplasma gondii Immune Responses in BALB/c Mice Induced by DNA Vaccines Encoding Surface Antigen 1 (SAG1) and 3 (SAG3). Molecular Genetics Microbiology and Virology 2019; 34: 59-66.
202
Karakavuk M, Can H, Gül A, Döşkaya AD, Alak SE, Ün C, et al. GRA8 DNA vaccine formulations protect against chronic toxoplasmosis. Microb Pathoge 2021; 158: 105016.
203
Li TT, Wang JL, Liang QL, Sun LX, Zhang HS, Zhang ZW, et al. Effect of deletion of gra17 and gra23 genes on the growth, virulence, and immunogenicity of type II Toxoplasma gondii. Parasitol Res 2020; 119: 2907-16.
204
Foroutan M, Ghaffarifar F, Sharifi Z, Dalimi A. Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice. Comp Immunol Microbiol Infect Dis 2020; 69: 101413.
205
Foroutan M, Barati M, Ghaffarifar F. Enhancing immune responses by a novel multi-epitope ROP8 DNA vaccine plus interleukin-12 plasmid as a genetic adjuvant against acute Toxoplasma gondii infection in BALB/c mice. Microb Pathog 2020; 147: 104435.
206
Sun H, Li J, Xiao T, Huang XD, Wang LJ, Huang BC, et al. Protective immunity induced by a DNA vaccine cocktail expressing TgSAG1, TgROP2, and the genetic adjuvant HBsAg against Toxoplasma gondii infection. Microb Pathog 2020; 147: 104441.
207
Arcon N, Picchio MS, Fenoy IM, Moretta RE, Soto AS, Sibilia MDP, et al. Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection. Vaccine 2021; 39: 933-42.
208
Dodangeh S, Fasihi-Ramandi M, Daryani A, Valadan R, Asgarian-Omran H, Hosseininejad Z, et al. Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB/c mice. Microb Pathog 2021; 153: 104764.
209
Pagheh AS, Daryani A, Alizadeh P, Hassannia H, Oliveira SMR, Kazemi T, et al. Protective effect of a DNA vaccine cocktail encoding ROP13 and GRA14 with Alum nano-adjuvant against Toxoplasma gondii infection in mice. Int J Biochem Cell Biol 2021; 132: 105920.
210
Khodadadi M, Ghaffarifar F, Dalimi A, Ahmadpour E. Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB/c mice. Acta Trop 2021; 216: 105836.
211
Yu Z, Chen S, Aleem M, He S, Yang Y, Zhou T, et al. Histone deacetylase SIR2 in Toxoplasma gondii modulates functions of murine macrophages in vitro and protects mice against acute toxoplasmosis in vivo. Microb Pathog 2021; 154: 104835.
